President of Outsourcing Support Services, a consulting company that specializes in non-clinical study monitoring and research operations improvements, Mr. Snyder has over 35 years of industry experience in non-clinical toxicology including positions at Charles River Laboratories, Wyeth, McNeil Pharmaceutical, and Eli Lilly, where he managed the general toxicology component. At Charles River, he became familiar with the inner workings of a CRO with responsibilities in marketing, business development, and project management. Mr. Snyder has been consulting for 12 years with clients ranging from large pharmaceutical organizations to virtual biotechnology companies and consulting firms. He is familiar with the management teams at, and the capabilities of, most non-clinical CROs. He leverages his strong background in regulatory compliance and his years of experience to mitigate the risk of outsourcing for his clients, and is regarded as an industry expert in non-clinical outsourcing and research operations, having written extensively on these topics in the trade publication Contract Pharma and his own blog on LinkedIn.